A new Northwestern Medicine study has revealed a connection between COVID-19 infection and cancer regression, which could pave the way for novel cancer treatments.
The COVID-19 virus spreads via mucus once inside an infected airway, according to a Northwestern Medicine study published in Nature Communications.
Feinberg medical students, trainees and faculty gathered to appreciate the artistic talents of the Feinberg community at an art fair held October 24.
Ten years after undergoing bariatric surgery as teens, over half of study participants demonstrated not only sustained weight loss, but also resolution of obesity-related conditions, such as type 2 diabetes, high blood pressure and high cholesterol.
Long-term treatment with the drug upadacitinib significantly improved symptoms and quality of life compared to placebo in adolescents with moderate to severe atopic dermatitis after 76 weeks with strong evidence of safety, according to a recent Northwestern Medicine analysis of three international, randomized clinical trials.
Two students in Feinberg’s Physician Assistant Program and two MD students have been awarded scholarships from the National Health Service Corps Scholarship Program.
Just two years out from its launch, the Center for Human Immunobiology has quickly become a bustling hub for collaborative efforts to understand the molecular mechanisms of the immune system and translate discoveries into innovative cures for immune-regulated diseases.
A Northwestern University-led team of engineers has developed a new type of wearable device that stimulates skin to deliver various complex sensations, providing more realistic and immersive sensory experiences.
Northwestern scientists, clinicians, and members of the ALS community gathered in the Feinberg Pavilion for the 14th annual Les Turner Symposium on ALS to celebrate progress and share the latest research in hopes of better understanding and treating the disease.
In research published in Science Advances, scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for Huntington’s disease, an incurable, debilitating illness that causes nerve cells to break down in the brain.